Why focus on Lp(a)?
Video navigation menu
- Overview on lipoproteins 0:21
- What is Lp(a)? 2:04
- Lp(a) and CVD 4:55
- Lp(a) reduction 6:50
Do you measure Lp(a) in all your patients?
- Yes, at least once in all adult patients
- No, only in those with high LDL-c levels
- No, because there is no therapy
This lecture by prof. Naveed Sattar was part of an accredited symposium "Lp(a): from CV risk marker to therapeutic target" held during the virtual ESC Congress 2021.
Naveed Sattar, MD, PhD is Professor of Metabolic Medicine, University of Glasgow. He is an academic (active clinically) experienced in biomarker studies/trials investigating the causes, prevention and management of diabetes, obesity and heart disease.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
Funding for this educational program was provided by unrestricted educational grants received from Sanofi and Novartis.